DN
David Nierengarten Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
38
Avg Return
Past Year
Past Year
27%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
91.7%
Neutral
8.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Technology
Consumer Discretionary
Residential Construction
Restaurants
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Solar
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Reiterated
| $25 |
126%
upside
| 1 | +2.8% |
0
%
| 25 Nov ‘25 8 days ago |
|
|
|
Outperform
Maintained
| $1,000 |
8%
upside
| 2 | +10% |
0
%
| 14 Nov ‘25 19 days ago |
|
|
|
Neutral
Maintained
| $7 |
23%
downside
| 1 | – |
–
| 7 Nov ‘25 26 days ago |
|
|
|
Outperform
Upgraded
| $7 |
548%
upside
| 1 | -35% |
0
%
| 27 Oct ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $110 |
19%
upside
| 1 | +24% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $70 |
60%
upside
| 1 | +68% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $44 |
8%
upside
| 1 | +43% |
0
%
| 13 Oct ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $6 |
28%
downside
| 2 | +47% |
0
%
| 13 Oct ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $115 |
8%
upside
| 1 | +32% |
0
%
| 8 Sep ‘25 2 months ago |
|
|
|
Outperform
Initiated
| $4 |
54%
upside
| 1 | +69% |
0
%
| 8 Sep ‘25 2 months ago |
|